Star Defender Listed as a Healthy Scratch for Crucial Week 5 Matchup
GERN Stock | USD 1.45 0.03 2.03% |
About 62% of Geron's investor base is looking to short. The analysis of the overall investor sentiment regarding Geron suggests that many traders are alarmed. Geron's investing sentiment overview a quick insight into current market opportunities from investing in Geron. Many technical investors use Geron stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Los Angeles Rams star defender TreDavious White has been ruled out as a healthy scratch in the Week 5 matchup against the Green Bay Packers.
Read at newsweek.com
![]() |
Geron Fundamental Analysis
We analyze Geron's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Geron using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Geron based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Working Capital
Working Capital Comparative Analysis
Geron is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
Geron Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Geron stock to make a market-neutral strategy. Peer analysis of Geron could also be used in its relative valuation, which is a method of valuing Geron by comparing valuation metrics with similar companies.
Peers
Geron Related Equities
XFOR | X4 Pharmaceuticals | 16.61 | ||||
IMMX | Immix Biopharma | 15.31 | ||||
VKTX | Viking Therapeutics | 1.76 | ||||
TGTX | TG Therapeutics | 0.96 | ||||
PTCT | PTC Therapeutics | 0.90 | ||||
PDSB | PDS Biotechnology | 0.63 | ||||
MDGL | Madrigal Pharmaceuticals | 1.40 | ||||
ZURA | Zura Bio | 1.92 | ||||
ENVB | Enveric Biosciences | 2.42 | ||||
ELEV | Elevation Oncology | 3.03 | ||||
SRPT | Sarepta Therapeutics | 3.15 | ||||
HEPA | Hepion Pharmaceuticals | 8.33 |
Check out Geron Hype Analysis, Geron Correlation and Geron Performance. To learn how to invest in Geron Stock, please use our How to Invest in Geron guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Geron. If investors know Geron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Geron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Geron is measured differently than its book value, which is the value of Geron that is recorded on the company's balance sheet. Investors also form their own opinion of Geron's value that differs from its market value or its book value, called intrinsic value, which is Geron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Geron's market value can be influenced by many factors that don't directly affect Geron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Geron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Geron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Geron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.